| abstract |
Low hygroscopic crystalline forms of aripiprazole identified as A, B, C, D, E, F and G and processes to prepare them, which will not become a hydrate or lose their original solubility, even if a medicinal preparation containing aripiprazole anhydride crystals for a prolonged period. Processes for preparing granules of said forms and solid pharmaceutical perforations for oral administration that comprise them. Use of such forms to prepare application medications in the treatment of central nervous system disorders such as schizophrenia and bipolar disorders. |